<?xml version="1.0" encoding="UTF-8"?><courses><course acad_year="2014" cat_num="1295" offered="Y">
<term term_pattern_code="1" fall_term="Y" spring_term="N">fall term</term>
<department code="MDSC">
<dept_long_name>Division of Medical Sciences</dept_long_name>
<dept_short_name>Medical Sciences</dept_short_name>
</department>
<course_group code="BCMP">BCMP</course_group>
<course_number>
<num_int>230</num_int>
</course_number>
<title>Principles and Practice of Drug Development</title>
<course_type>Lecture</course_type>
<course_level code="T">Primarily for Graduates</course_level>
<credit code="1">Half course</credit>
<meeting_text>Th., 3-6</meeting_text>
<faculty_text>Lee L. Rubin and Stan Neil Finkelstein (Medical School)</faculty_text>
<description>Critical assessment of the major issues and stages of developing a pharmaceutical or biopharmaceutical. Drug discovery, preclinical development, clinical investigation, manufacturing and regulatory issues considered for small and large molecules. Economic considerations of the drug development process.</description>
<prerequisites/>
<notes>Classes held at MIT. BCMP 230 is also offered as SCRB 230. Students may not take both for credit.</notes>
<instructor_approval_required>N</instructor_approval_required>
<faculty_list>
<faculty term="1" role="H" id="Fa771e8ae46afb8bc82db510244e58374">
<name>
<prefix/>
<first>Lee</first>
<middle/>
<last>Rubin</last>
<suffix/>
</name>
</faculty>
<faculty term="1" role="O" id="F418b328d6c9a0929d7b7bf791670ef77">
<name>
<prefix/>
<first>Stan</first>
<middle>Neil</middle>
<last>Finkelstein</last>
<suffix/>
</name>
</faculty>
</faculty_list>
<schedule>
<meeting term="1" optional="N" type="Lecture" day="4" begin_time="1500" end_time="1800"/>
</schedule>
<meeting_locations/>
<requirements/>
</course></courses>